KF
Kevin Feeley
Chief Financial Officer

Kevin Feeley insider trades: GeneDx Holdings (WGS) stock sales

Chief Financial Officer, GeneDx Holdings Last trade Sep 16, 2026 68 Form 4 filings
$2.6M
Sold, last 12 months
12 sales
$0
Bought, last 12 months
0 buys
61
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

61 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 16, 2026WGS↓ Sell$364K
Sep 9, 2026WGS↓ Sell$108K
Sep 1, 2026WGS↓ Sell$31K
Jun 16, 2026WGS↓ Sell$227K
Jun 9, 2026WGS↓ Sell$68K
Jun 1, 2026WGS↓ Sell$19K
Mar 16, 2026WGS↓ Sell$438K
Mar 4, 2026WGS↓ Sell$486K
Jan 29, 2026WGS↓ Sell$30K
Dec 16, 2025WGS↓ Sell$555K
Dec 9, 2025WGS↓ Sell$202K
Dec 1, 2025WGS↓ Sell$61K
Oct 29, 2025WGS↓ Sell$53K
Sep 30, 2025WGS↓ Sell$716K
Sep 16, 2025WGS↓ Sell$453K
Sep 9, 2025WGS↓ Sell$163K
Sep 2, 2025WGS↓ Sell$48K
Jul 29, 2025WGS↓ Sell$41K
Jul 9, 2025WGS↓ Sell$491K
Jul 1, 2025WGS↓ Sell$122K
Jun 16, 2025WGS↓ Sell$242K
Jun 9, 2025WGS↓ Sell$92K
Jun 2, 2025WGS↓ Sell$26K
Apr 29, 2025WGS↓ Sell$44K
Apr 9, 2025WGS↓ Sell$1.4M
Mar 26, 2025WGS↓ Sell$836K
Mar 17, 2025WGS↓ Sell$399K
Mar 10, 2025WGS↓ Sell$87K
Mar 3, 2025WGS↓ Sell$27K
Jan 29, 2025WGS↓ Sell$22K
Jan 7, 2025WGS↓ Sell$3.3M
Jan 2, 2025WGS↓ Sell$109K
Dec 16, 2024WGS↓ Sell$286K
Dec 9, 2024WGS↓ Sell$87K
Dec 2, 2024WGS↓ Sell$21K
Nov 22, 2024WGS↓ Sell$1.6M
Oct 29, 2024WGS↓ Sell$18K
Sep 16, 2024WGS↓ Sell$99K
Sep 9, 2024WGS↓ Sell$30K
Sep 3, 2024WGS↓ Sell$8K
Jul 29, 2024WGS↓ Sell$9K
Jun 17, 2024WGS↓ Sell$75K
Jun 10, 2024WGS↓ Sell$22K
Jun 3, 2024WGS↓ Sell$5K
Apr 29, 2024WGS↓ Sell$12K
Mar 18, 2024WGS↓ Sell$34K
Mar 12, 2024WGS↓ Sell$9K
Mar 4, 2024WGS↓ Sell$3K
Dec 18, 2023WGS↓ Sell$6K
Dec 11, 2023WGS↓ Sell$1K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other WGS insiders

Open-market trades in the last 12 months

About Kevin Feeley's insider trades

Kevin Feeley is Chief Financial Officer at GeneDx Holdings (WGS). Since Dec 2, 2022, Kevin has reported no open-market purchases and 61 sales worth $13.8M on SEC Form 4. In the last 12 months: 12 sales ($2.6M).

Their filings also include option exercises (58 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WGS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.